Arsenic(III) sulfide structure
|
Common Name | Arsenic(III) sulfide | ||
---|---|---|---|---|
CAS Number | 1303-33-9 | Molecular Weight | 248.05400 | |
Density | 3.43 g/mL at 25ºC(lit.) | Boiling Point | 707ºC | |
Molecular Formula | As2H2S3 | Melting Point | 300ºC(lit.) | |
MSDS | Chinese USA | Flash Point | 707°C | |
Symbol |
GHS06, GHS09 |
Signal Word | Danger |
Name | Arsenic(III) sulfide |
---|---|
Synonym | More Synonyms |
Density | 3.43 g/mL at 25ºC(lit.) |
---|---|
Boiling Point | 707ºC |
Melting Point | 300ºC(lit.) |
Molecular Formula | As2H2S3 |
Molecular Weight | 248.05400 |
Flash Point | 707°C |
Exact Mass | 247.77500 |
PSA | 89.48000 |
LogP | 1.40800 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS06, GHS09 |
---|---|
Signal Word | Danger |
Hazard Statements | H301 + H311 + H331-H410 |
Precautionary Statements | P261-P273-P280-P301 + P310-P311-P501 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
Hazard Codes | T:Toxic; N:Dangerous for the Environment; |
Risk Phrases | R23/25;R50/53 |
Safety Phrases | S1/2-S20/21-S28-S45-S60-S61 |
RIDADR | UN 1557 6.1/PG 2 |
WGK Germany | 3 |
RTECS | CG2638000 |
Packaging Group | III |
Hazard Class | 6.1 |
Arsenic sulfide, the main component of realgar, a traditional Chinese medicine, induces apoptosis of gastric cancer cells in vitro and in vivo.
Drug Des. Devel. Ther. 9 , 79-92, (2015) Arsenic sulfide (As4S4), the main component of realgar, a traditional Chinese medicine, has shown antitumor efficacy in several tumor types, especially for acute promyelocytic leukemia. In this study,... |
|
As4S4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia.
Proc. Natl. Acad. Sci. U. S. A. 107(50) , 21683-8, (2010) Arsenic, a curative agent for acute promyelocytic leukemia, induces cell apoptosis and degradation of BCR-ABL in chronic myelogenous leukemia (CML). We demonstrated that ubiquitination and degradation... |
|
A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemia.
Proc. Natl. Acad. Sci. U. S. A. 106(9) , 3378-83, (2009) In this study, we show that combined use of Imatinib (IM) and arsenic sulfide [As(4)S(4) (AS)] exerts more profound therapeutic effects in a BCR/ABL-positive mouse model of chronic myeloid leukemia (C... |
MFCD00003435 |
EINECS 215-117-4 |